Statin use and risk of bladder cancer: a meta-analysis (Q34325144)

1 August 2017

0 references

Statin use and risk of bladder cancer: a meta-analysis (English)

1 reference

1 August 2017

1 reference

Xiao-long Zhang

1

1 reference

1 August 2017

Jiang Geng

2

1 reference

1 August 2017

Xiao-peng Zhang

3

1 reference

1 August 2017

Bo Peng

4

1 reference

1 August 2017

Jian-ping Che

5

1 reference

1 August 2017

Guang-chun Wang

7

1 reference

1 August 2017

Sheng-qiang Xia

8

1 reference

1 August 2017

Yan Wu

9

1 reference

1 August 2017

Jun-hua Zheng

10

1 reference

1 August 2017

Yang Yan

6

1 reference

1 August 2017

30 January 2013

1 reference

1 August 2017

Cancer Causes & Control

1 reference

1 August 2017

24

1 reference

1 August 2017

769-776

1 reference

1 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s10552-013-0159-3

1 August 2017

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Carcinogenicity of lipid-lowering drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Statins have biphasic effects on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Atorvastatin: a potential chemopreventive agent in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Statin use and cancer risk in the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Statin use and the risk of 10 cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

The association between statins and cancer incidence in a veterans population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Incidence of cancer and statin usage--record linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Statin use and the risk of bladder cancer: a population-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Exposure to statins and risk of common cancers: a series of nested case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Statins and cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Statins and risk of cancer: a systematic review and metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Statins and cancer: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Controlling the risk of spurious findings from meta-regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

Statins for people at low risk of cardiovascular disease – Authors' reply

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0159-3

10.1007/S10552-013-0159-3

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference